-
1
-
-
33748779525
-
Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography
-
Anastos N, Barnett NW, Pfeffer FM, and Lewis SW (2006) Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography. Sci Justice 46:91-96.
-
(2006)
Sci Justice
, vol.46
, pp. 91-96
-
-
Anastos, N.1
Barnett, N.W.2
Pfeffer, F.M.3
Lewis, S.W.4
-
2
-
-
67651162416
-
Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials
-
Bjornstad K, Hulten P, Beck O, and Helander A (2009) Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials. Clin Toxicol (Phila) 47:566-572.
-
(2009)
Clin Toxicol (Phila)
, vol.47
, pp. 566-572
-
-
Bjornstad, K.1
Hulten, P.2
Beck, O.3
Helander, A.4
-
3
-
-
26444551640
-
S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): Role of UGT2B7 in the elimination of naproxen
-
Bowalgaha K, Elliot DJ, Mackenzie PI, Knights KM, Swedmark S, and Miners JO (2005) S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen. Br J Clin Pharmacol 60:423-433.
-
(2005)
Br J Clin Pharmacol
, vol.60
, pp. 423-433
-
-
Bowalgaha, K.1
Elliot, D.J.2
Mackenzie, P.I.3
Knights, K.M.4
Swedmark, S.5
Miners, J.O.6
-
4
-
-
0034714343
-
Glucuronidation of apomorphine
-
El-Bachá RS, Leclerc S, Netter P, Magdalou J, and Minn A (2000) Glucuronidation of apomorphine. Life Sci 67:1735-1745.
-
(2000)
Life Sci
, vol.67
, pp. 1735-1745
-
-
El-Bachá, R.S.1
Leclerc, S.2
Netter, P.3
Magdalou, J.4
Minn, A.5
-
5
-
-
0034009448
-
In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin
-
Fisher MB, Campanale K, Ackermann BL, VandenBranden M, and Wrighton SA (2000) In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560-566.
-
(2000)
Drug Metab Dispos
, vol.28
, pp. 560-566
-
-
Fisher, M.B.1
Campanale, K.2
Ackermann, B.L.3
VandenBranden, M.4
Wrighton, S.A.5
-
6
-
-
33846549510
-
Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior
-
González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, and Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439-452.
-
(2007)
Neuron
, vol.53
, pp. 439-452
-
-
González-Maeso, J.1
Weisstaub, N.V.2
Zhou, M.3
Chan, P.4
Ivic, L.5
Ang, R.6
Lira, A.7
Bradley-Moore, M.8
Ge, Y.9
Zhou, Q.10
Sealfon, S.C.11
Gingrich, J.A.12
-
8
-
-
2542460170
-
Hallucinogens and dissociative agents naturally growing in the United States
-
Halpern JH (2004) Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 102:131-138.
-
(2004)
Pharmacol Ther
, vol.102
, pp. 131-138
-
-
Halpern, J.H.1
-
9
-
-
0037026358
-
Renal excretion profiles of psilocin following oral administration of psilocybin: A controlled study in man
-
Hasler F, Bourquin D, Brenneisen R, and Vollenweider FX (2002) Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. J Pharm Biomed Anal 30:331-339.
-
(2002)
J Pharm Biomed Anal
, vol.30
, pp. 331-339
-
-
Hasler, F.1
Bourquin, D.2
Brenneisen, R.3
Vollenweider, F.X.4
-
10
-
-
0030960090
-
Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man
-
Hasler F, Bourquin D, Brenneisen R, Bär T, and Vollenweider FX (1997) Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv 72:175-184.
-
(1997)
Pharm Acta Helv
, vol.72
, pp. 175-184
-
-
Hasler, F.1
Bourquin, D.2
Brenneisen, R.3
Bär, T.4
Vollenweider, F.X.5
-
12
-
-
0037159194
-
Activation of glucuronidation through reduction of a disulfide bond in rat UDP-glucuronosyltransferase 1A6
-
Ikushiro S, Emi Y, and Iyanagi T (2002) Activation of glucuronidation through reduction of a disulfide bond in rat UDP-glucuronosyltransferase 1A6. Biochemistry 41:12813-12820.
-
(2002)
Biochemistry
, vol.41
, pp. 12813-12820
-
-
Ikushiro, S.1
Emi, Y.2
Iyanagi, T.3
-
13
-
-
63849180294
-
Dopamine is a low-affinity and high-specificity substrate for the human UDPglucuronosyltransferase 1A10
-
Itäaho K, Court MH, Uutela P, Kostiainen R, Radominska-Pandya A, and Finel M (2009) Dopamine is a low-affinity and high-specificity substrate for the human UDPglucuronosyltransferase 1A10. Drug Metab Dispos 37:768-775.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 768-775
-
-
Itäaho, K.1
Court, M.H.2
Uutela, P.3
Kostiainen, R.4
Radominska-Pandya, A.5
Finel, M.6
-
14
-
-
54349124543
-
The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP- glucuronosyltransferases
-
Itäaho K, Mackenzie PI, Ikushiro S, Miners JO, and Finel M (2008) The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP- glucuronosyltransferases. Drug Metab Dispos 36:2307-2315.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 2307-2315
-
-
Itäaho, K.1
Mackenzie, P.I.2
Ikushiro, S.3
Miners, J.O.4
Finel, M.5
-
15
-
-
67650821911
-
Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers
-
Izukawa T, Nakajima M, Fujiwara R, Yamanaka H, Fukami T, Takamiya M, Aoki Y, Ikushiro S, Sakaki T, and Yokoi T (2009) Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos 37:1759-1768.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1759-1768
-
-
Izukawa, T.1
Nakajima, M.2
Fujiwara, R.3
Yamanaka, H.4
Fukami, T.5
Takamiya, M.6
Aoki, Y.7
Ikushiro, S.8
Sakaki, T.9
Yokoi, T.10
-
16
-
-
47949097984
-
Regioand stereospecific N-glucuronidation of medetomidine: The differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes
-
Kaivosaari S, Toivonen P, Aitio O, Sipilä J, Koskinen M, Salonen JS, and Finel M (2008) Regioand stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos 36:1529-1537.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1529-1537
-
-
Kaivosaari, S.1
Toivonen, P.2
Aitio, O.3
Sipilä, J.4
Koskinen, M.5
Salonen, J.S.6
Finel, M.7
-
17
-
-
31344479074
-
Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: Identification and quantification of its urinary metabolites
-
Kamata T, Katagi M, Kamata HT, Miki A, Shima N, Zaitsu K, Nishikawa M, Tanaka E, Honda K, and Tsuchihashi H (2006) Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites. Drug Metab Dispos 34:281-287.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 281-287
-
-
Kamata, T.1
Katagi, M.2
Kamata, H.T.3
Miki, A.4
Shima, N.5
Zaitsu, K.6
Nishikawa, M.7
Tanaka, E.8
Honda, K.9
Tsuchihashi, H.10
-
18
-
-
33747502854
-
Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: Time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a "magic mushroom" user
-
Kamata T, Nishikawa M, Katagi M, and Tsuchihashi H (2006) Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a "magic mushroom" user. Forensic Toxicol 24:36-40.
-
(2006)
Forensic Toxicol
, vol.24
, pp. 36-40
-
-
Kamata, T.1
Nishikawa, M.2
Katagi, M.3
Tsuchihashi, H.4
-
21
-
-
0000574406
-
Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites
-
Korzekwa KR, Krishnamachary N, Shou M, Ogai A, Parise RA, Rettie AE, Gonzalez FJ, and Tracy TS (1998) Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37:4137-4147.
-
(1998)
Biochemistry
, vol.37
, pp. 4137-4147
-
-
Korzekwa, K.R.1
Krishnamachary, N.2
Shou, M.3
Ogai, A.4
Parise, R.A.5
Rettie, A.E.6
Gonzalez, F.J.7
Tracy, T.S.8
-
22
-
-
0038685671
-
Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6
-
Krishnaswamy S, Duan SX, Von Moltke LL, Greenblatt DJ, and Court MH (2003) Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Dispos 31:133-139.
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 133-139
-
-
Krishnaswamy, S.1
Duan, S.X.2
Von Moltke, L.L.3
Greenblatt, D.J.4
Court, M.H.5
-
23
-
-
3242685873
-
Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6
-
Krishnaswamy S, Hao Q, Von Moltke LL, Greenblatt DJ, and Court MH (2004) Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6. Drug Metab Dispos 32:862-869.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 862-869
-
-
Krishnaswamy, S.1
Hao, Q.2
Von Moltke, L.L.3
Greenblatt, D.J.4
Court, M.H.5
-
24
-
-
33847043537
-
Interactions with other human UDP- glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6
-
Kurkela M, Patana AS, Mackenzie PI, Court MH, Tate CG, Hirvonen J, Goldman A, and Finel M (2007) Interactions with other human UDP- glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6. Pharmacogenet Genomics 17:115-126.
-
(2007)
Pharmacogenet Genomics
, vol.17
, pp. 115-126
-
-
Kurkela, M.1
Patana, A.S.2
Mackenzie, P.I.3
Court, M.H.4
Tate, C.G.5
Hirvonen, J.6
Goldman, A.7
Finel, M.8
-
25
-
-
25144500468
-
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
-
Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685.
-
(2005)
Pharmacogenet Genomics
, vol.15
, pp. 677-685
-
-
Mackenzie, P.I.1
Bock, K.W.2
Burchell, B.3
Guillemette, C.4
Ikushiro, S.5
Iyanagi, T.6
Miners, J.O.7
Owens, I.S.8
Nebert, D.W.9
-
26
-
-
0019857227
-
Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy
-
Migliaccio GP, Shieh TL, Byrn SR, Hathaway BA, and Nichols DE (1981) Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy. J Med Chem 24:206-209.
-
(1981)
J Med Chem
, vol.24
, pp. 206-209
-
-
Migliaccio, G.P.1
Shieh, T.L.2
Byrn, S.R.3
Hathaway, B.A.4
Nichols, D.E.5
-
27
-
-
47949110575
-
Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines
-
Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, and Yokoi T (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461-1464.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1461-1464
-
-
Nakamura, A.1
Nakajima, M.2
Yamanaka, H.3
Fujiwara, R.4
Yokoi, T.5
-
28
-
-
58149467072
-
Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction
-
Ohno S and Nakajin S (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32-40.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 32-40
-
-
Ohno, S.1
Nakajin, S.2
-
29
-
-
0038542220
-
-
Shirota O, Hakamata W, and Goda Y (2003) Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of magic mushroom. J Nat Prod 66:885-887.
-
Shirota O, Hakamata W, and Goda Y (2003) Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom." J Nat Prod 66:885-887.
-
-
-
-
30
-
-
73949103669
-
-
Sneitz N, Court MH, Zhang X, Laajanen K, Yee KK, Dalton P, Ding X, and Finel M (2009) Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A. Pharmacogenet Genomics.
-
Sneitz N, Court MH, Zhang X, Laajanen K, Yee KK, Dalton P, Ding X, and Finel M (2009) Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A. Pharmacogenet Genomics.
-
-
-
-
32
-
-
0343878143
-
Detection of psilocin in body fluids
-
Sticht G and Käferstein H (2000) Detection of psilocin in body fluids. Forensic Sci Int 113:403-407.
-
(2000)
Forensic Sci Int
, vol.113
, pp. 403-407
-
-
Sticht, G.1
Käferstein, H.2
-
33
-
-
0345725004
-
Morphological and chemical analysis of magic mushrooms in Japan
-
Tsujikawa K, Kanamori T, Iwata Y, Ohmae Y, Sugita R, Inoue H, and Kishi T (2003) Morphological and chemical analysis of magic mushrooms in Japan. Forensic Sci Int 138: 85-90.
-
(2003)
Forensic Sci Int
, vol.138
, pp. 85-90
-
-
Tsujikawa, K.1
Kanamori, T.2
Iwata, Y.3
Ohmae, Y.4
Sugita, R.5
Inoue, H.6
Kishi, T.7
-
34
-
-
0034128936
-
Human UDP-glucuronosyltransferases: Metabolism, expression, and disease
-
Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616.
-
(2000)
Annu Rev Pharmacol Toxicol
, vol.40
, pp. 581-616
-
-
Tukey, R.H.1
Strassburg, C.P.2
-
35
-
-
0035103197
-
Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members
-
Turgeon D, Carrier JS, Lévesque E, Hum DW, and Bélanger A (2001) Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787.
-
(2001)
Endocrinology
, vol.142
, pp. 778-787
-
-
Turgeon, D.1
Carrier, J.S.2
Lévesque, E.3
Hum, D.W.4
Bélanger, A.5
|